The pro-inflammatory cytokines in the endometrium can alter the natural path of action of insulin in PCOS patients through a variety of mechanisms leading to IR, disrupted glucose metabolism in the endometrium, and impaired receptor capacity. This evidence concerns the gene INS and polycystic ovary syndrome.